Astrana Health, Inc.
corporate_fare Company Profile
Astrana Health, Inc. (NASDAQ:ASTH) is a publicly traded company in the Life Sciences sector. Wiseek monitors ASTH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Astrana Health ACOs Generate $120.4M in Shared Savings, Validating Value-Based Model
- Astrana Health ACOs Deliver $120.4M in Gross Shared Savings for 2024 Performance Year
- Shareholders Approve 1 Million Share Increase for Equity Incentive Plan
- Astrana Health Reports Robust Q1 2026 Results with 56% Revenue Growth and Doubled Net Income
- Astrana Health Projects Q2 Revenue Between $965M and $1B
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for ASTH, detected from its recent SEC filings · based on capital-structure filings through 2026-03-30.
Employee Stock Purchase Plan (ESPP) Registration · Potential Future Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →